Cited by 143Cardiac electrophysiology and arrhythmiasAtrial Fibrillation Management and OutcomesCardiac Arrhythmias and Treatments

Cardiac adrenergic control and atrial fibrillation

Open access
Workman, Antony J.·2010·Naunyn-Schmiedeberg's Archives of Pharmacology

Abstract

Atrial fibrillation (AF) is the most common cardiac arrhythmia, and it causes substantial mortality. The autonomic nervous system, and particularly the adrenergic/cholinergic balance, has a profound influence on the occurrence of AF. Adrenergic stimulation from catecholamines can cause AF in patients. In human atrium, catecholamines can affect each of the electrophysiological mechanisms of AF initiation and/or maintenance. Catecholamines may produce membrane potential oscillations characteristic of afterdepolarisations, by increasing Ca(2+) current, [Ca(2+)](i) and consequent Na(+)-Ca(2+) exchange, and may also enhance automaticity. Catecholamines might affect reentry, by altering excitability or conduction, rather than action potential terminal repolarisation or refractory period. However, which arrhythmia mechanisms predominate is unclear, and likely depends on cardiac pathology and adrenergic tone. Heart failure (HF), a major cause of AF, causes adrenergic activation and adaptational changes, remodelling, of atrial electrophysiology, Ca(2+) homeostasis, and adrenergic responses. Chronic AF also remodels these, but differently to HF. Myocardial infarction and AF cause neural remodelling that also may promote AF. beta-Adrenoceptor antagonists (beta-blockers) are used in the treatment of AF, mainly to control the ventricular rate, by slowing atrioventricular conduction. beta-Blockers also reduce the incidence of AF, particularly in HF or after cardiac surgery, when adrenergic tone is high. Furthermore, the chronic treatment of patients with beta-blockers remodels the atria, with a potentially antiarrhythmic increase in the refractory period. Therefore, the suppression of AF by beta-blocker treatment may involve an attenuation of arrhythmic activity that is caused by increased [Ca(2+)](i), coupled with effects of adaptation to the treatment. An improved understanding of the involvement of the adrenergic system and its control in basic mechanisms of AF under differing cardiac pathologies might lead to better treatments.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00210-009-0474-0

Cites

161 of 161 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Hoogsteen et al discuss atrial fibrillation being triggered by adrenergic surges during exercise in younger athletes, whereas older athletes typically experience vagally induced atrial fibrillation after exercise, normally from secondary autonomic dysfunction.

    “Investigating the mechanistic underpinning of this age-dependant risk, Hoogsteen et al 24 discuss AF being triggered by adrenergic surges occurring during exercise in younger athletes, 25 whereas older athletes typically experience vagally induced AF after exercise, normally from secondary autonomic dysfunction.26”

    From Risk of atrial fibrillation in athletes: a systematic review and meta-analysis (2021) · cites this paper as [25]

    Split into 2 atoms — 0 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 1 unverifiable. Expand the claim to see per-atom verdicts.

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

9 of the 170 references couldn’t be matched to a known paper.

Research works printed but not linked: 7

  1. Christ T Boknik P Wohrl S L-type Ca2+ current downregulation in chronic human atrial fibrillation is associated with increased activity of protein phosphatases Circulation 2004 110 2651 2657 15492323
  2. Ehrlich JR Nattel S Novel approaches for pharmacological management of atrial fibrillation Drugs 2009 69 757 774 19441867
  3. Kecskemeti V Kelemen K Solti F Physiological and pharmacological analysis of transmembrane action potentials of human atrial fibers Adv Myocardiol 1985 6 37 47 3887530
  4. Mary-Rabine L Hordof AJ Danilo P Jr. Mechanisms for impulse initiation in isolated human atrial fibers Circ Res 1980 47 267 277 7397958
  5. Wang C Zhang YJ Wang YL Effect of dipfluzine on delayed afterdepolarizations and triggered activity induced by isoprenaline in human atrial fibers Acta Pharmaceutica Sinica 2006 41 184 187 16671553
  6. Workman AJ Rankin AC Serotonin, If and human atrial arrhythmia Cardiovasc Res 1998 40 436 437 10070482
  7. Workman AJ Kane KA Rankin AC Cellular bases for human atrial fibrillation Heart Rhythm 2008 5 S1 S6 18456193 PMC2639647

Cited by

Sorted by citations

Authors
Workman, A. J.
Affiliations
British Heart Foundation (GB)
Corresponding author
Workman, Antony J.
Venue
Naunyn-Schmiedeberg's Archives of Pharmacology
Published
2009-12-04
Volume
381
Issue
3
Pages
235-249
ISSN
  • 0028-1298 (ISSN-L)
  • 1432-1912
OpenAlex
W2012942841
Cited by
143
References
170
Citations by year
2026: 10 · 2025: 5 · 2024: 10 · 2023: 15 · 2022: 6 · 2021: 8 · 2020: 10 · 2019: 8 · 2018: 2 · 2017: 6 · 2016: 4 · 2015: 7 · 2014: 11 · 2013: 17 · 2012: 10
FWCI
1.20
Type
journal article
Language
en
Open access
Locations
  • Naunyn-Schmiedeberg s Archives of Pharmacology (publishedVersion)
  • PubMed (publishedVersion)
  • ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
British Heart Foundation (BS/06/003, BS/06/003/20338)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Arrhythmias and Treatments
Keywords
atrial fibrillation, adrenergic system, catecholamines, autonomic nervous system, beta-blockers, heart failure, atrial remodeling, calcium homeostasis, afterdepolarizations, automaticity, reentry, atrial electrophysiology, cardiac surgery
MeSH terms
Action Potentials, Adrenergic beta-Antagonists, Animals, Atrial Fibrillation, Catecholamines, Humans, Receptors, Adrenergic, Species Specificity, Calcium Signaling

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review